GlassScriptPhysician profile
Matthew C Farrugia
NPI 1821016098
$11,406.29
in general payments reported to CMS, 2019-2025
23 companies · $2,998 in 2025
The $2,998 reported for 2025 was more than what 93% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $772 · 2020: $302 · 2021: $1,010 · 2022: $1,809 · 2023: $1,982 · 2024: $2,533 · 2025: $2,998.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,479 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,479.14 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $1,837.31 | 2019-2024 | Acclarent Navwire, Acclarent Aera, Relieva Spinplus |
| Integra Lifesciences Corporation | $1,775.60 | 2019-2025 | Integra, Trudi Probe, Inspira Air |
| Medtronic, INC. | $1,479.72 | 2021-2025 | Propel, Stealthstation S8 Platform, Nim Vital |
| Glaxosmithkline, LLC. | $868.50 | 2022-2025 | Nucala |
| Stryker Corporation | $775.23 | 2019-2025 | Xpress Ent Dilation System, Xpress Loprofile, 1788 |
| Regeneron Healthcare Solutions, INC. | $632.21 | 2020-2025 | Dupixent |
| Aerin Medical INC. | $604.82 | 2019-2025 | |
| Genzyme Corporation | $596.26 | 2021-2025 | |
| Intersect Ent, INC. | $537.41 | 2019-2022 | |
| Inspire Medical Systems, INC. | $406.52 | 2023-2025 | Inspire |
| Alk-Abello, INC | $406.22 | 2019-2024 | Grastek, Odactra, Ragwitek |
| Hologic Sales and Service, LLC | $383.08 | 2023-2025 | Coolseal Generator |
| Ars Pharmaceuticals Operations, INC. | $302.50 | 2025 | Neffy |
| Neurent Medical Limited | $170.74 | 2024 | Neuromark Device, Neuromark Radiofrequency Console |
| Checkpoint Surgical, INC | $132.60 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanara Medtech INC. | $127.98 | 2024 | Celleraterx |
| Optinose US, INC. | $125.00 | 2025 | |
| Smith+Nephew, INC. | $77.94 | 2020-2024 | |
| Abbvie INC. | $60.62 | 2024 | |
| Amgen INC. | $54.44 | 2025 | Tezspire |
| Precigen, INC. | $19.28 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $17.82 | 2025 | Tezspire |
| Hikma Pharmaceuticals USA | $14.49 | 2023 | Ryaltris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Farrugia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.